Paraganglioma immunohistochemistry explained

Immunohistochemistry applies laboratory antibodies to tissue sections so selected proteins appear as stained signals. In a suspected paraganglioma, the pathologist assesses the pattern in the main tumour cells and in the supporting sustentacular cells. Findings such as neuroendocrine marker staining and the presence or absence of sustentacular-cell staining can support the interpretation, but no single marker is read in isolation. A marker called SDHB may be included because loss of its staining can raise the possibility of an SDH-related tumour and prompt consideration of inherited risk.

Ask the pathology or oncology team to explain which markers were tested, whether the pattern supports paraganglioma, and whether another tumour remains possible. The report is combined with the biopsy appearance, scan findings, hormone tests, symptoms, and tumour location. If the pattern raises an inherited-risk question, genetic counselling and testing may be discussed for you and, where relevant, relatives. Do not interpret a positive stain as proof that a tumour will behave aggressively; behaviour is assessed using the whole clinical picture and follow-up.

Seek urgent medical help for sudden severe headache, chest pain, fainting, marked palpitations, heavy sweating with weakness, or very high blood pressure, particularly if a paraganglioma is suspected. After a biopsy, contact the team for persistent bleeding, increasing swelling, fever, or worsening pain. These symptoms can have causes unrelated to the tumour, but they should be assessed promptly.

Which markers were positive or negative? Does the pattern support paraganglioma? Was SDHB staining performed? Do I need hormone testing, scans, or genetic counselling? Who will explain the final pathology and follow-up plan?